GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » E10

Zhejiang Starry Pharmaceutical Co (SHSE:603520) E10 : ¥0.43 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥-0.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.43 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-02), Zhejiang Starry Pharmaceutical Co's current stock price is ¥8.92. Zhejiang Starry Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥0.43. Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio of today is 20.74.

During the past 13 years, the highest Shiller PE Ratio of Zhejiang Starry Pharmaceutical Co was 25.70. The lowest was 14.53. And the median was 19.58.


Zhejiang Starry Pharmaceutical Co E10 Historical Data

The historical data trend for Zhejiang Starry Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Starry Pharmaceutical Co E10 Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.62

Zhejiang Starry Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.62 0.56 0.51 0.43

Competitive Comparison of Zhejiang Starry Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Zhejiang Starry Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Starry Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.04/115.7848*115.7848
=-0.040

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Starry Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.750 99.000 0.877
201503 0.139 99.900 0.161
201506 0.031 99.500 0.036
201509 0.029 100.500 0.033
201512 0.080 100.600 0.092
201603 0.102 102.200 0.116
201606 0.062 101.400 0.071
201609 0.047 102.400 0.053
201612 0.040 102.600 0.045
201703 0.084 103.200 0.094
201706 0.080 103.100 0.090
201709 0.047 104.100 0.052
201712 0.040 104.500 0.044
201803 0.066 105.300 0.073
201806 0.130 104.900 0.143
201809 0.082 106.600 0.089
201812 0.027 106.500 0.029
201903 0.122 107.700 0.131
201906 0.163 107.700 0.175
201909 0.129 109.800 0.136
201912 0.100 111.200 0.104
202003 0.136 112.300 0.140
202006 0.286 110.400 0.300
202009 0.179 111.700 0.186
202012 0.114 111.500 0.118
202103 0.186 112.662 0.191
202106 0.274 111.769 0.284
202109 0.180 112.215 0.186
202112 0.300 113.108 0.307
202203 0.240 114.335 0.243
202206 -0.050 114.558 -0.051
202209 -0.130 115.339 -0.131
202212 -0.280 115.116 -0.282
202303 0.030 115.116 0.030
202306 0.070 114.558 0.071
202309 0.010 115.339 0.010
202312 0.020 114.781 0.020
202403 0.040 115.227 0.040
202406 0.024 114.781 0.024
202409 -0.040 115.785 -0.040

Add all the adjusted EPS together and divide 10 will get our e10.


Zhejiang Starry Pharmaceutical Co  (SHSE:603520) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Starry Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.92/0.43
=20.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zhejiang Starry Pharmaceutical Co was 25.70. The lowest was 14.53. And the median was 19.58.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Starry Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Zhejiang Starry Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Starry Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director

Zhejiang Starry Pharmaceutical Co Headlines

No Headlines